- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01410682
Oral Care and Gram-negative Pathogen in Children
August 4, 2011 updated by: Federal University of São Paulo
Oral Care and Oropharyngeal and Tracheal Colonization by Gram-negative Pathogens in Children
Critical care nursing interventions related to oral care can reduce the microorganisms in the oropharynx available for translocation to other sites.
THis is a randomized, controlled and double blinded study performed in a pediatric intensive care unit (PICU) from a Brazilian university hospital which objectives were to analyze 0.12% chlorhexidine digluconate influence on Gram-negative pathogens colonization of oropharyngeal and tracheal secretions of mechanically ventilated children.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
74
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 weeks to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All the PICU children during 24 months of study were selected for participation.
Exclusion Criteria:
- newborns, those that fulfilled the Centers for Disease Control and Prevention criteria for pneumonia in infants and children at the time of PICU admission, PICU LOS less than 48 hours, presence of tracheostomy and those that declined to participate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 0.12% Chlorhexidine Digluconate
Oral care included use of an oral gel containing chlorhexidine digluconate 0.12% as an active ingredient (chlorhexidine digluconate 0.12%; methylcellulose gel 2.12%, 25 g; gooseberry syrup, 4 drops; menthol solution 50%,3 drops; and distilled water, to 30 g).The gel is applied on a toothbrush, and the teeth are cleaned in quadrants; all teeth surfaces are cleaned (vestibular,lingual, occlusal, and incisal).
After each quadrant was cleaned, 10 mL of water (dispensed via a syringe) is used to rinse the quadrant and continual aspiration is used to remove all the gel and debris.
After all the teeth are cleaned, the ventral surface of the tongue is brushed with posteriorto- anterior movements.
|
Oral care with 0.12% Chlorhexidine Digluconate and toothbrushing is realized twice a day and took about 10 minutes to complete, depending on the child's acceptance and clinical conditions.
|
|
Placebo Comparator: tothbrushing
This group received the same oral care that experimental group with the use of a similarly formulated gel without the antiseptic agent.The gel is applied on a toothbrush, and the teeth are cleaned in quadrants; all teeth surfaces are cleaned (vestibular, lingual, occlusal, and incisal).
After each quadrant is cleaned, 10 mL of water (dispensed via a syringe) is used to rinse the quadrant and continual aspiration is used to remove all the gel and debris.
After all the teeth are cleaned, the ventral surface of the tongue is brushed with posterior to anterior movements.
|
Gel is applied on a toothbrush, and the teeth are cleaned in quadrants; all teeth surfaces are cleaned (vestibular, lingual, occlusal, and incisal).
After each quadrant is cleaned, 10 mL of water (dispensed via a syringe) is used to rinse the quadrant and continual aspiration is used to remove all the gel and debris.
After all the teeth are cleaned, the ventral surface of the tongue is brushed with posterior to anterior movements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Influence of chlorhexidine digluconate 0.12% on tracheal and oropharyngeal colonization by gram-negative pathogens
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Influence of some demographic characteristics of critically ill children on the oropharynx Gram-negative pathogens identification.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2005
Primary Completion (Actual)
June 1, 2007
Study Completion (Actual)
June 1, 2007
Study Registration Dates
First Submitted
August 4, 2011
First Submitted That Met QC Criteria
August 4, 2011
First Posted (Estimate)
August 5, 2011
Study Record Updates
Last Update Posted (Estimate)
August 5, 2011
Last Update Submitted That Met QC Criteria
August 4, 2011
Last Verified
July 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ORAL CARE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tracheal and Oropharyngeal Colonization by Gram-negative Pathogens
-
Assistance Publique - Hôpitaux de ParisCompletedOropharyngeal Gram-negative Bacilli ColonizationFrance
-
Assistance Publique - Hôpitaux de ParisCompletedOropharyngeal Gram-negative Bacilli ColonizationFrance
-
Emory UniversityCenters for Disease Control and PreventionRecruitingIntestinal Multi-drug Resistant Organism ColonizationUnited States
-
Johns Hopkins Bloomberg School of Public HealthBill and Melinda Gates Foundation; International Centre for Diarrhoeal Disease...CompletedStunting | Campylobacter Infections | Malnutrition; Protein | Enteric PathogensBangladesh
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedMulti-drug Resistant Gram-negative Bacilli ColonizationUnited States
-
Tata Memorial CentreAll India Institute of Medical Sciences, New Delhi; Amrita Institute of Medical...Not yet recruitingStage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8India
-
Mayo ClinicRecruitingClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma... and other conditionsUnited States
-
Hospital Italiano de Buenos AiresNot yet recruitingCarbapenemase-Producing Enterobacterales (CPE) Colonization
-
Mayo ClinicActive, not recruitingClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Human Papillomavirus-Related Carcinoma | Locally Advanced Oropharyngeal CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma... and other conditionsUnited States
Clinical Trials on 0,12% digluconate chlorhexidine
-
Cairo UniversityNot yet recruiting
-
Masaryk UniversityCompletedChlorhexidine | Oral Microbiota | Saliva Microbiome | Antimicrobial Resistance (AMR) | Oral Microbiome HealthCzechia
-
University of L'AquilaCompleted
-
University of LjubljanaRecruitingPeriodontitisSlovenia
-
University of LjubljanaCompleted
-
Istanbul Medeniyet UniversityCompletedVentilator Associated PneumoniaTurkey
-
University of TaubateConselho Nacional de Desenvolvimento Científico e TecnológicoUnknownPeriodontitis | Normal Blood PressureBrazil
-
Okan UniversityCompletedSkin | Health Care Associated InfectionTurkey